Statistical methods for cost-effectiveness analysis of left-truncated and right-censored survival data with treatment delays is a research paper published in Journal of the Royal Statistical Society Series C (Applied Statistics) (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R01AI112339 and DP1ES025459
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords